ClinVar Miner

Submissions for variant NM_201384.3(PLEC):c.8801C>T (p.Thr2934Met)

gnomAD frequency: 0.00013  dbSNP: rs368122904
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000369753 SCV000333703 uncertain significance not provided 2015-08-21 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000529817 SCV000650453 uncertain significance Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy 2023-11-24 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 2961 of the PLEC protein (p.Thr2961Met). This variant is present in population databases (rs368122904, gnomAD 0.03%). This missense change has been observed in individual(s) with arthrogryposis (PMID: 31230720). ClinVar contains an entry for this variant (Variation ID: 282308). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV000764749 SCV000895887 uncertain significance Epidermolysis bullosa simplex 5B, with muscular dystrophy; Junctional epidermolysis bullosa with pyloric atresia; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy 2018-10-31 criteria provided, single submitter clinical testing
GeneDx RCV000369753 SCV001765174 uncertain significance not provided 2023-09-26 criteria provided, single submitter clinical testing Observed with a missense variant on the opposite allele (in trans) in a patient with distal arthrogryposis in the literature, although additional clinical information was limited (Pehlivan et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; This variant is associated with the following publications: (PMID: 34426522, 31230720)
Revvity Omics, Revvity RCV000369753 SCV003816678 uncertain significance not provided 2020-10-06 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV005355588 SCV005912553 uncertain significance Autosomal recessive limb-girdle muscular dystrophy 2021-07-30 criteria provided, single submitter research
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine RCV001007791 SCV001167477 uncertain significance Autosomal recessive limb-girdle muscular dystrophy type 2Q no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.